254 related articles for article (PubMed ID: 34976925)
1. A Cross-Sectional Survey to Assess Biorisk Management System in Research and Diagnostic Laboratories in Khyber Pakhtunkhwa, Pakistan.
Muhammad J; Sarwar S; Khan T; Qasmi SA; Ikram A; Ahmad G; Zahid M; Durrani RH; Ahmed F
Front Public Health; 2021; 9():766162. PubMed ID: 34976925
[TBL] [Abstract][Full Text] [Related]
2. Assessment of biosafety implementation in clinical diagnostic laboratories in Pakistan during the COVID-19 pandemic.
Sarwar S; Shahzad F; Vajeeha A; Munir R; Yaqoob A; Naeem A; Sattar M; Gull S
J Biosaf Biosecur; 2022 Jun; 4(1):43-49. PubMed ID: 35072000
[TBL] [Abstract][Full Text] [Related]
3. [Biorisk Management for Clinical Diagnostic Laboratories].
Shigematsu M
Rinsho Byori; 2016 Nov; 64(11):1279-1289. PubMed ID: 30695310
[TBL] [Abstract][Full Text] [Related]
4. Biosafety and biosecurity measures: management of biosafety level 3 facilities.
Zaki AN
Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S70-4. PubMed ID: 20801002
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of international virtual training on biorisk management in the context of COVID-19.
Qasmi SA; Standley C; Mohsin S; Sarwar S; Malik L; Aziz F
Front Public Health; 2022; 10():888097. PubMed ID: 36339241
[TBL] [Abstract][Full Text] [Related]
6. Strengthening Biorisk Management Capacities in Burkina Faso: Contribution of the Global Health Security Agenda.
Dama E; Orelle A; Nikiema A; Mandingar PD; Naby A; Bationo GB; Kéita MS; Pierson A; Sawadogo C; Koné RG
Health Secur; 2022; 20(6):479-487. PubMed ID: 36399610
[TBL] [Abstract][Full Text] [Related]
7. A Mentorship Program to Develop Biorisk Manuals for Laboratories in Pakistan.
Sarwar S; Moreno MMN; Chaudhri M; Aamir UB; Ikram A
Appl Biosaf; 2022 Dec; 27(4):219-224. PubMed ID: 36761992
[TBL] [Abstract][Full Text] [Related]
8. Harmonization of European laboratory response networks by implementing CWA 15793: use of a gap analysis and an "insider" exercise as tools.
Sundqvist B; Bengtsson UA; Wisselink HJ; Peeters BP; van Rotterdam B; Kampert E; Bereczky S; Johan Olsson NG; Szekely Björndal A; Zini S; Allix S; Knutsson R
Biosecur Bioterror; 2013 Sep; 11 Suppl 1():S36-44. PubMed ID: 23971820
[TBL] [Abstract][Full Text] [Related]
9. A Multilingual Tool for Standardized Laboratory Biosafety and Biosecurity Assessment and Monitoring.
Orelle A; Nikiema A; Zakaryan A; Albetkova AA; Keita MS; Rayfield MA; Peruski LF; Pierson A
Health Secur; 2022; 20(6):488-496. PubMed ID: 36383124
[TBL] [Abstract][Full Text] [Related]
10. WHO Laboratory Biosafety Manual: A New Approach to Security.
Ficociello B; Giordano D; Incoronato F; Farinella A; Pietrangeli B
Ann Work Expo Health; 2023 Apr; 67(4):425-429. PubMed ID: 36495279
[TBL] [Abstract][Full Text] [Related]
11. Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017.
Appelt S; Jacob D; Rohleder AM; Bråve A; Szekely Björndal Å; Di Caro A; Grunow R;
Euro Surveill; 2020 Sep; 25(36):. PubMed ID: 32914748
[TBL] [Abstract][Full Text] [Related]
12. Strengthening Biorisk Management in Research Laboratories with Security-Sensitive Biological Agents Like SARS-CoV-2.
Phyu S; Joseph T; Goulart M
Methods Mol Biol; 2022; 2452():395-439. PubMed ID: 35554919
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the Biosafety and Biosecurity in the Reference Veterinary Laboratory of Parakou in Benin.
Sodjinou VD; Ayelo PA; Achade AGA; Affolabi D; Ouendo DE
Trop Med Infect Dis; 2021 Aug; 6(3):. PubMed ID: 34449734
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the Biosafety and Biosecurity Landscape in the Philippines and the Development of the National Biorisk Management Framework.
Destura RV; Lam HY; Navarro RC; Lopez JCF; Sales RKP; Gomez MIFA; Dela Tonga A; Ulanday GE
Appl Biosaf; 2021 Dec; 26(4):232-244. PubMed ID: 36034094
[No Abstract] [Full Text] [Related]
15. Biorisk Management for SARS-CoV-2 Research in a Biosafety Level-3 Core Facility.
Joseph T; Phyu S; Se-Thoe SY; Chu JJH
Methods Mol Biol; 2022; 2452():441-464. PubMed ID: 35554920
[TBL] [Abstract][Full Text] [Related]
16. Biosafety Initiatives in BMENA Region: Identification of Gaps and Advances.
Khan E; Ahmed N; Temsamani KR; El-Gendy A; Cohen M; Hasan A; Gastfriend H; Cole J
Front Public Health; 2016; 4():44. PubMed ID: 27047912
[TBL] [Abstract][Full Text] [Related]
17. Challenges in Implementing a Biorisk Management Program at Universitas Indonesia: A Checklist Tool for Biorisk Management.
Naroeni A; Bachtiar EW; Ibrahim F; Bela B; Kusminanti Y; Pujiriani I; Lestari F
Health Secur; 2016; 14(6):375-381. PubMed ID: 27830940
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the Biorisk Status of Veterinary Laboratories in Southwest Nigeria: Application of the Food and Agriculture Organization Laboratory Mapping Tool-Safety Module.
Adebowale O; Oduguwa A; Dipeolu S; Agbaje M; Fasanmi O; Fasina FO
Appl Biosaf; 2020 Dec; 25(4):232-239. PubMed ID: 36032392
[TBL] [Abstract][Full Text] [Related]
19. Application of Biosafety Principles in Laboratory Analysis of Clinical Samples from Patients with COVID-19.
Hussain Gardezi SA; Ikram A
J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S48-S51. PubMed ID: 32515375
[TBL] [Abstract][Full Text] [Related]
20. The Biosafety Research Road Map: The Search for Evidence to Support Practices in the Laboratory-SARS-CoV-2.
Blacksell SD; Dhawan S; Kusumoto M; Le KK; Summermatter K; O'Keefe J; Kozlovac J; Almuhairi SS; Sendow I; Scheel CM; Ahumibe A; Masuku ZM; Kojima K; Harper DR; Hamilton K
Appl Biosaf; 2023 Jun; 28(2):87-95. PubMed ID: 37342515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
